INFLARX NV (IFRX) Fundamental Analysis & Valuation

NASDAQ:IFRX • NL0012661870

Current stock price

1.08 USD
+0.08 (+8%)
Last:

This IFRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IFRX Profitability Analysis

1.1 Basic Checks

  • In the past year IFRX has reported negative net income.
  • IFRX had a negative operating cash flow in the past year.
  • IFRX had negative earnings in each of the past 5 years.
  • In the past 5 years IFRX always reported negative operating cash flow.
IFRX Yearly Net Income VS EBIT VS OCF VS FCFIFRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -61.55%, IFRX is not doing good in the industry: 60.66% of the companies in the same industry are doing better.
  • IFRX's Return On Equity of -88.40% is in line compared to the rest of the industry. IFRX outperforms 46.71% of its industry peers.
Industry RankSector Rank
ROA -61.55%
ROE -88.4%
ROIC N/A
ROA(3y)-59.58%
ROA(5y)-48.8%
ROE(3y)-75.47%
ROE(5y)-60.62%
ROIC(3y)N/A
ROIC(5y)N/A
IFRX Yearly ROA, ROE, ROICIFRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IFRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IFRX Yearly Profit, Operating, Gross MarginsIFRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IFRX Health Analysis

2.1 Basic Checks

  • IFRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IFRX has been increased compared to 1 year ago.
  • The number of shares outstanding for IFRX has been increased compared to 5 years ago.
  • IFRX has a worse debt/assets ratio than last year.
IFRX Yearly Shares OutstandingIFRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
IFRX Yearly Total Debt VS Total AssetsIFRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • IFRX has an Altman-Z score of -6.45. This is a bad value and indicates that IFRX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -6.45, IFRX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.02 indicates that IFRX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.02, IFRX is in line with its industry, outperforming 45.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -6.45
ROIC/WACCN/A
WACC7.37%
IFRX Yearly LT Debt VS Equity VS FCFIFRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 3.33 indicates that IFRX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.33, IFRX is in line with its industry, outperforming 40.31% of the companies in the same industry.
  • IFRX has a Quick Ratio of 3.06. This indicates that IFRX is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 3.06, IFRX is not doing good in the industry: 60.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 3.06
IFRX Yearly Current Assets VS Current LiabilitesIFRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IFRX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.19% over the past year.
  • Looking at the last year, IFRX shows a very negative growth in Revenue. The Revenue has decreased by -82.33% in the last year.
EPS 1Y (TTM)15.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)-82.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3300%

3.2 Future

  • Based on estimates for the next years, IFRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.65% on average per year.
  • Based on estimates for the next years, IFRX will show a very strong growth in Revenue. The Revenue will grow by 274.06% on average per year.
EPS Next Y25.15%
EPS Next 2Y12.21%
EPS Next 3Y5.24%
EPS Next 5Y10.65%
Revenue Next Year1221.94%
Revenue Next 2Y402.79%
Revenue Next 3Y241.65%
Revenue Next 5Y274.06%

3.3 Evolution

IFRX Yearly Revenue VS EstimatesIFRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
IFRX Yearly EPS VS EstimatesIFRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. IFRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IFRX. In the last year negative earnings were reported.
  • Also next year IFRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFRX Price Earnings VS Forward Price EarningsIFRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IFRX Per share dataIFRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.21%
EPS Next 3Y5.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IFRX Dividend Analysis

5.1 Amount

  • IFRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IFRX Fundamentals: All Metrics, Ratios and Statistics

INFLARX NV

NASDAQ:IFRX (4/13/2026, 3:55:04 PM)

1.08

+0.08 (+8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-19
Earnings (Next)05-05
Inst Owners27.25%
Inst Owner Change0%
Ins Owners5.97%
Ins Owner Change0%
Market Cap78.07M
Revenue(TTM)29.30K
Net Income(TTM)-40.10M
Analysts81.43
Price Target9.03 (736.11%)
Short Float %4.04%
Short Ratio6.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.91%
Min EPS beat(2)-16.54%
Max EPS beat(2)-11.29%
EPS beat(4)2
Avg EPS beat(4)17.88%
Min EPS beat(4)-16.54%
Max EPS beat(4)68.63%
EPS beat(8)3
Avg EPS beat(8)1.85%
EPS beat(12)7
Avg EPS beat(12)12.99%
EPS beat(16)10
Avg EPS beat(16)16.59%
Revenue beat(2)0
Avg Revenue beat(2)-45.63%
Min Revenue beat(2)-67.47%
Max Revenue beat(2)-23.79%
Revenue beat(4)0
Avg Revenue beat(4)-73.03%
Min Revenue beat(4)-100.86%
Max Revenue beat(4)-23.79%
Revenue beat(8)1
Avg Revenue beat(8)-66.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.33%
PT rev (3m)-23.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)27.7%
EPS NY rev (3m)27.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)14.52%
Revenue NY rev (3m)14.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1054.85
P/FCF N/A
P/OCF N/A
P/B 1.47
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0
BVpS0.73
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.55%
ROE -88.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.58%
ROA(5y)-48.8%
ROE(3y)-75.47%
ROE(5y)-60.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.73%
Cap/Sales 206.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 3.06
Altman-Z -6.45
F-Score1
WACC7.37%
ROIC/WACCN/A
Cap/Depr(3y)17.18%
Cap/Depr(5y)16.88%
Cap/Sales(3y)183.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y25.15%
EPS Next 2Y12.21%
EPS Next 3Y5.24%
EPS Next 5Y10.65%
Revenue 1Y (TTM)-82.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3300%
Revenue Next Year1221.94%
Revenue Next 2Y402.79%
Revenue Next 3Y241.65%
Revenue Next 5Y274.06%
EBIT growth 1Y20.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.88%
EBIT Next 3Y3.05%
EBIT Next 5YN/A
FCF growth 1Y10.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.59%
OCF growth 3YN/A
OCF growth 5YN/A

INFLARX NV / IFRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INFLARX NV?

ChartMill assigns a fundamental rating of 2 / 10 to IFRX.


What is the valuation status of INFLARX NV (IFRX) stock?

ChartMill assigns a valuation rating of 0 / 10 to INFLARX NV (IFRX). This can be considered as Overvalued.


What is the profitability of IFRX stock?

INFLARX NV (IFRX) has a profitability rating of 0 / 10.


What is the financial health of INFLARX NV (IFRX) stock?

The financial health rating of INFLARX NV (IFRX) is 3 / 10.


What is the expected EPS growth for INFLARX NV (IFRX) stock?

The Earnings per Share (EPS) of INFLARX NV (IFRX) is expected to grow by 25.15% in the next year.